Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer

Analytical and Quantitative Cytology and Histology

Volumn 24, Issue 6, 2002, Pages 345-354

  Pinto, António E ^a,b   Mendonça, Evelina ^a   André, Saudade ^a   Nóbrega, Sónia D ^a   Soares, Jorge ^a  

^a Instituto Portugus de Oncologia de Francisco Gentil   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Aspiration biopsy; Breast cancer; Estrogen receptors; Flow cytometry; Progesterone receptors; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; DNA;

ADULT; ADVANCED CANCER; AGED; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; BREAST; BREAST TUMOR; EVALUATION; GENETICS; METABOLISM; METHODOLOGY; MORTALITY; PATHOLOGY; PLOIDY; SURVIVAL RATE;

ADULT; AGED; BREAST; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; S PHASE; SURVIVAL RATE;

EID: 0036899298     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A: 14 Years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353:1903-1908
2. Amadori D, Volpi A, Maltoni R, Nanni O, Amaducci L, Amadori A, Giunchi DC, Vio A, Saragoni A, Silvestrini R: Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study. Breast Cancer Res Treat 1997;43:7-14
3. Baldetorp B, Bendahl P-O, Fernö M, Alanen K, Delle U, Falkmer U, Hansson-Aggesjö B, Höckenström T, Lindgren A, Mossberg L, Nordling S, Sigurdsson H, Stål O, Visakorpi T: Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories' results for 67 sample homogenates. Cytometry 1995;22:115-127
4. Barnes DM, Hanby AM: Oestrogen and progesterone receptors in breast cancer: Past, present and future. Histopathology 2001;38:271-274
5. Beerman H, Kluin M, Hermans J, van de Velde CJH, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 1990;45:34-39
6. Bergers E, Baak JPA, van Diest PJ, van Gorp LHM, Kwee WS, Los J, Peterse HL, Ruitenberg HM, Schapers RFM, Somsen JG, van Beek MWPM, Bellot SM, Fijnheer J: Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the multicenter morphometric mammary carcinoma project (MMMCP). Int J Cancer 1997;74:260-269
7. Bonetti A, Zaninelli M, Rodella S, Molini A, Sperotto L, Piubello Q, Bonetti F, Nortilli R, Turazza M, Cetto GL: Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma. Breast Cancer Res Treat 1996;38:289-297
8. Coombes RC, Powles TJ, Berger U, Wilson P, McClelland RA, Gazet JC, Trott PA, Ford HT: Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine needle aspirates. Lancet 1987;2:701-703
9. Cox DR: Regression models and life tables. J R Stat Soc B 1972;34:187-220
10. Dean PN, Jett JH: Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60:523-527
11. Deitch AD, Law H, White RD: A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 1982;30:967-972
12. Ewers SB, Langstrom E, Baldetorp B, Killander D: Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 1984;5:408-419
13. Fernando IN, Powles TJ, Dowsett M, Ashley S, McRobert BL, Titley J, Ormerod MG, Sacks N, Nicolson MC, Nash A, Ford HT, Allan SM, Trott PA: Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry. Virchows Arch 1995;426:155-161
14. Frierson HF Jr: Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast. Am J Surg Pathol 1991;15:358-367
15. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE: Follow-up after 11 years: Update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-270
16. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M: AJCC Cancer Staging Handbook. Sixth Edition. New York, Springer-Verlag, 2002, pp 257-281
17. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D: Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993;14:482-485
18. Hietanen P, Blomqvist C, Wasenius V-M, Niskanen E, Franssila K, Nordling S: Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer? Br J Cancer 1995;71:1029-1032
19. Joensuu H, Alanen K, Falkmer UG, Klemi P, Nordling S, Remvikos Y, Toikkanen S: Effect of DNA ploidy classification on prognosis in breast cancer. Int J Cancer 1992;52:701-706
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
21. King WJ, Greene GL: Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 1984;307: 745-747
22. Levack PA, Mullen P, Anderson TJ, Miller WR, Forrest APM: DNA analysis of breast tumour fine needle aspirates using flow cytometry. Br J Cancer 1987;56:643-646.
23. Mansour EG, Ravdin PM, Dressler L: Prognostic factors in early breast carcinoma. Cancer 1994;74:381-400
24. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170
25. O'Reilly SM, Camplejohn RS, Rubens RD, Richards MA: DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. Eur J Cancer 1992;28:681-683
26. Pinto AE, André S, Nogueira M, Mendonça E, Soares J: Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer. J Clin Pathol 1997;50:591-595
27. Pinto AE, André S, Pereira T, Nóbrega S, Soares J: Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma. J Clin Pathol 2001;54:543-549
28. Pinto AE, André S, Soares J: Short term significance of DNA ploidy and cell proliferation in breast carcinoma: A multivariate analysis of prognostic markers in a series of 308 patients. J Clin Pathol 1999;52:604-611
29. Remvikos Y, Beuzeboc P, Zadjela A, Voillemot N, Magdelénal H, Pouillart P: Correlation of pretreatment proliferative activity of breast cancer with response to cytotoxic chemotherapy. J Natl Cancer Inst 1989;81:1383-1387
30. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-477
31. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J: Flow cytometry in primary breast cancer: Improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 1990;62:786-790
32. Tavassoli FA: Pathology of the Breast. Second Edition. Stamford, Connecticut, Appleton & Lange, 1999, pp 37-56
33. Trott PA: Aspiration cytodiagnosis of the breast. Diagn Oncol 1991;1:79-87
34. Wenger CR, Clark GM: S-phase fraction and breast cancer: A decade of experience. Breast Cancer Res Treat 1998;51:255-265
35. Winstanley J, Cooke T, George WD, Murray G, Holt S, Croton R, Griffiths K, Nicholson R: The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 1991;64:99-101
36. Zafrani B, Aubriot M-H, Mouret E, de Crémoux P, de Rycke Y, Nicolas A, Boudou E, Vincent-Salomon A, Magdelénat H, Sastre-Garau X: High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: Comparison with biochemical determination in a prospective study of 793 cases. Histopathology 2000;37:536-545